STAFF BOARD
Article
CHAIRMAN
Virginia Hernández Corredoira
EDITOR IN CHIEF
Manuela Velázquez Prieto
Jaime E. Poquet Jornet
MARKETING MANAGER
EDITORIAL BOARD
Ramón Jódar Masanés
Lluís Campins Bernadas
Tomás Casasín Edo
Juan Carlos Juárez Giménez
Carles Quiñones Ribas
Volume 22 - Issue 2, April-June 2020
SHORT REPORTS
MONITORING THE USE OF LINEZOLID IN A THIRD-LEVEL HOSPITAL
SANABRIAS FERNÁNDEZ DE SEVILLA RAQUEL, FOLGUERA OLÍAS CARLOS, CALVO SALVADOR MARINA, MENCHÉN VISO BELÉN, GARCÍA CEREZUELA MARÍA DOLORES, REPILADO ÁLVAREZ ADRIÁN, SÁNCHEZ GUERRERO AMELIA


The inappropriate use of antibiotics is a clinical reality that we are currently facing. The purpose of this observational and retrospective study is to analyze the evolution of linezolid (LNZ) consumption from 2009 to 2017 in general in
a third-level hospital and in critical care services, and see if the introduction of the generic LNZ produced an increase in its use. The variables analyzed were: variation of global LNZ consumption by years (%), DDD/100 stays for year of
LNZ, variation of consumption in A-R service (%) and variation of consumption in ICU service (%). The increase in LNZ consumption appeared one year before the availability of its generic equivalent. In the critical units, the consumption was affected differently, increasing in A-R to a lesser extent (14.5%) and one year later than in ICU, in which it increased very significantly (54.35%) and coinciding with the access to its generic equivalent (2016). The introduction of the generic LNZ contributed, along with other factors, to explain the increase in consumption of it
in our hospital.

CONSUMPTION – CRITICAL CARE – GENERIC – LINEZOLID



Fill out the form below to buy this article

Name and surname:

DNI/NIF ID/VAT IDENTIFICATION No.:

Contact Email:

Phone:

Address:

Zip code:

City:

Province:

Country:

*I have read and accept the privacy policy
Price : 30,25